Feminizing Treatment in Transgender Women and Non-binary Persons

Recruiting

• Conditions: Transgenderism
• Interventions: Other: standard treatment

• Registration Number: NCT05169762
• Lead Sponsor: Odense University Hospital

Brief Summary

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.

Detailed Description

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years,

Outcomes:

Non-calcified and calcified plaque formation by contras coronary CT angiograms Heartfunction by ekko Cardiovaskular risk markers, f. eks. bp Markers of cardiovascular risk in blood and urine

Study Timeline

• Study First Submitted: 2021-09-19
• Study First Submitted QC: 2021-12-23
• Study First Posted: 2021-12-27
• Study Start: 2022-02-01
• Status Verified: 2022-11
• Last Update Submitted: 2022-11-23
• Last Update Posted: 2022-11-25
• Primary Completion: 2035-09-01
• Study Completion: 2035-09-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

• assigned male at birth and eligeble for gender affirming feminizing treatment

Read More

Exclusion Criteria

none

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
transgender women	standard treatment	transgender women eligeble to start gender affirming hormone treatment

Primary Outcome Measures

Name	Time	Method
coronary plaque formation	1 year	mm3

Trial Locations

Locations (1)

OdenseUH; 🇩🇰 Odense, Denmark